Adenoid Cystic Carcinoma - 45 Studies Found

Completed : A Study of Apatinib in Metastatic Adenoid Cystic Carcinoma of the Head and Neck
: Adenoid Cystic Carcinoma
: 2016-05-12
: Drug: Apatinib Mesylate Apatinib Mesylate will be administered orally at 500 mg once daily for 5 consecu
Not yet recruiting : Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
: Adenoid Cystic Carcinoma
: 2016-10-18
:
  • Drug: Apatinib Apatinib will b
Active, not recruiting : Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14
: Adenoid Cystic Carcinomas of the Salivary Glands
: 2016-08-02
: Drug: Lenvatinib Lenvatinib will be self orally administered at 24 mg daily, on a continuous basis in 4
Completed : A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
:
  • Adenoid Cystic Carcinoma
  • Salivary Gland Cancer

: 2009-04-20
: Drug: Sunitinib 37.5 mg taken orally, daily every 28-day cycles
Not yet recruiting : Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
: Adenocystic Carcinoma
: 2016-08-25
: Drug: Chidamide Other Name: epidaza
Completed : A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
:
  • Recurrent Adenoid Cystic Carcinoma of the Salivary Glands
  • Metas
    : 2012-08-23
    : Drug: Dovitinib Treatment continued until Disease Progression, Toxicity, or patient withdrawal
Completed : Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck
:
  • Cancer of the Head and Neck
  • Carcinoma, Adenoid Cystic

: 2005-09-13
: Drug: Imatinib
Active, not recruiting : Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
:
  • Recurrent Oral Cavity Adenoid Cystic Carcinoma
  • Recurrent Saliva
    : 2010-08-04
    :
    • Other: Laboratory Biomarker Analysis

Completed : Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
:
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • Recurrent
    : 2004-02-10
    :
    • Drug: bortezomib Given IV
Completed : Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma
: Recurrent ACC, metastaticACC, Unreaectable ACC
: 2016-07-28
:
  • Drug: Axitinib Dosing schedule
<<< Previous | Next >>>